| P50 | author | Eva Feldman | Q5415042 |
| | Lucy M Hinder | Q57023938 |
| | Subramaniam Pennathur | Q87965108 |
| | Claudia Figueroa-Romero | Q90615803 |
| | Crystal Pacut | Q125193378 |
| | Anuradha Vivekanandan-Giri | Q125193959 |
| P2093 | author name string | Yu Hong | |
| P2860 | cites work | Biochemistry and molecular cell biology of diabetic complications | Q28131781 |
| | Genomics of the human carnitine acyltransferase genes | Q28139379 |
| | Global risk management in type 2 diabetes: blood glucose, blood pressure, and lipids--update on the background of the current guidelines | Q28171307 |
| | Local regulation of fat metabolism in peripheral nerves | Q28510849 |
| | Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex | Q28567616 |
| | Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes | Q30514207 |
| | Diabetic neuropathy: mechanisms to management | Q33554384 |
| | Diabetes regulates mitochondrial biogenesis and fission in mouse neurons. | Q33571558 |
| | Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production | Q33571909 |
| | Long-chain acyl-CoA synthetases and fatty acid channeling | Q33757925 |
| | Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms | Q34104944 |
| | Assessing mitochondrial dysfunction in cells. | Q34793639 |
| | Role of the Schwann cell in diabetic neuropathy | Q34800415 |
| | Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes. | Q35063229 |
| | Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function | Q35138509 |
| | The identification of gene expression profiles associated with progression of human diabetic neuropathy | Q35540055 |
| | New insights into the mechanisms of diabetic neuropathy. | Q35813649 |
| | Oxidative stress in the pathogenesis of diabetic neuropathy | Q35856228 |
| | Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. | Q36203941 |
| | Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy. | Q36501212 |
| | Standardized bioenergetic profiling of adult mouse cardiomyocytes. | Q36530885 |
| | Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes | Q36879268 |
| | Glucose neurotoxicity | Q37038404 |
| | Mouse models of diabetic neuropathy | Q37062972 |
| | Elevated triglycerides correlate with progression of diabetic neuropathy | Q37236277 |
| | Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. | Q37360464 |
| | Fibrates and microvascular complications in diabetes--insight from the FIELD study | Q37387551 |
| | Hyperlipidemia: a new therapeutic target for diabetic neuropathy | Q37659233 |
| | Diabetic neuropathy: cellular mechanisms as therapeutic targets | Q37930962 |
| | The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy | Q39452399 |
| | Reducing time and increasing sensitivity in sample preparation for adherent mammalian cell metabolomics | Q39566477 |
| | Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic beta-cell line INS-1. | Q41133952 |
| | Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. | Q42003724 |
| | Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity | Q42159827 |
| | Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death | Q44779270 |
| | Short-term hyperglycemia produces oxidative damage and apoptosis in neurons | Q45242262 |
| | Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes | Q46673101 |
| | Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. | Q50757649 |
| | Neurons undergo apoptosis in animal and cell culture models of diabetes. | Q52536719 |
| | Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress | Q56610055 |
| P433 | issue | 4 | |
| P921 | main subject | fatty acid | Q61476 |
| | Schwann cell | Q465621 |
| | overexpression | Q61643320 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 588-600 | |
| P577 | publication date | 2013-10-05 | |
| P1433 | published in | Antioxidants & Redox Signaling | Q4775078 |
| P1476 | title | Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction | |
| P478 | volume | 21 | |